The Effecacy of Domperidone as a Preventing Emetic Agnet in Chemotherapy-Induced Emeses

Domperidone is a dopamin receptor blocker which is few adverses. Domperidone is admited by oral loaded dose and following by sublingual sustaining dose to prevert chemotherapy-induced emeses. The complete control rate of emese is 74.3% in containing MD-cisplatin regimens, 81.8% in containing middle-induced emeses agents and ondansetron is 74.0% in containgin MD-cisplatin regimens.Domperidone is not significant adverses and its expanse is much low.